Smoking boosts clopidogrel effect in diabetes patients with CAD

04/9/2012 | Medscape (free registration)

Data on 134 patients with type 2 diabetes and coronary artery disease who were on maintenance clopidogrel therapy showed that those who smoked were less likely to suffer from high on-treatment platelet reactivity than those who did not smoke. However, researchers warned that cardiovascular events, including mortality, remained high for those who smoked. The results were published in JACC: Cardiovascular Interventions.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC